Michelle Sodipo, Ph.D., M.S., M.P.H.
Michelle Sodipo, Ph.D., M.S., M.P.H., joined the NCI in May 2026 as a postdoctoral fellow in the Integrative Tumor Epidemiology Branch (ITEB) under the mentorship of Gretchen Gierach, Ph.D., M.P.H., ITEB Director and senior investigator.
Dr. Sodipo earned an M.P.H. in chronic disease epidemiology from Yale School of Public Health in 2021. She completed her M.S. in biostatistics and Ph.D. in population health sciences, with a focus in cancer epidemiology, at Harvard University in 2026. Dr. Sodipo’s graduate research focused on cancer survivorship.
In her doctoral research, she explored the effects of systemic therapies on trajectories of subjective cognitive function and survival among prostate cancer survivors. She also examined sociodemographic differences in measures of adherence to systemic treatments across data sources among breast cancer survivors.
In ITEB, Dr. Sodipo is studying treatment patterns and the effects of endocrine therapy on recurrence and second cancer development in the Kaiser Permanente Breast Cancer Survivors Cohort. She is also examining cancer health disparities among breast cancer survivors.